Paul Westwood

Allosteric Modulation of the Cannabinoid CB1 Receptor

M. R. Price, Gemma L. Baillie, Adèle Thomas et al. · Molecular Pharmacology · 2005 · 440 citations

Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity

Mark Baugh, Darcey Black, Paul Westwood et al. · Journal of Autoimmunity · 2011 · 72 citations

Rheumatology, Autoimmune Disease, Medicine +9

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Julia M. Adam, Jim Cairns, Wilson Caulfield et al. · MedChemComm · 2010 · 36 citations

Pharmaceutical Science, Drug Target, Pain Medicine +17

Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors

Peter C. Ray, Jane Wright, Julia Adam et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 29 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Natural Sciences +7

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

Combinatorial Chemistry, Cathepsin K Inhibitors, Medicinal Chemistry +10